PLAYMOBIL JUNIOR Advent Calendar Delivers on Sustainability: Trays Made from Renewable Materials by PAPACKS®
Zirndorf, September 2024 – PLAYMOBIL is staying true to its sustainability strategy with a new eco-friendly innovation. The latest PLAYMOBIL JUNIOR Advent Calendar ditches plastic for renewable materials from PAPACKS®, Europe’s leading producer of molded fiber packaging. This innovative solution eliminates single-use plastic from PLAYMOBIL’s toddler Advent calendars, marking a significant step towards comprehensive sustainability.
Tahsin Dag, Founder & CEO of PAPACKS®, says:
“Our collaboration with PLAYMOBIL is a bold statement for a sustainable future. Our fiber-based trays, made from renewable resources, offer a cutting-edge, eco-friendly alternative to single-use plastic. This not only ensures a sustainable holiday season but also inspires other companies to embrace the shift toward a plastic-free economy.”
Since the start of this year, over 90% of materials used in all PLAYMOBIL JUNIOR sets have been made from biobased plastics. These plastics follow a circular economy approach, using byproducts from food or paper production. The new materials in the product line for children aged 1 to 4 maintain PLAYMOBIL’s trusted quality—safe for children, durable, and easy to clean. The packaging also features recycled cardboard, and the new molded fiber inlays, crafted from renewable raw materials, are food-safe and child-friendly.
With this sustainable packaging solution for the Advent calendar trays, PLAYMOBIL JUNIOR and PAPACKS® are ensuring that the holiday season can be enjoyed in an eco-conscious way—while toddlers explore a world of fun.
The new PLAYMOBIL JUNIOR Advent Calendar Snowy Christmas (Item No.: 70297) is available wherever toys are sold.
Product Highlights Include:
- Reindeer plane with three attachable and combinable elements
- Six stackable footstep stones with control images on the underside
- Nine woodland animals
- Christmas tree with hidden compartments
- Spinning star
- Two angels and Santa Claus
- Dimensions of reindeer plane (without figures): approx. 23.5 x 12 x 5.5 cm
Christmas tree: approx. 10 x 5.5 x 13.5 cm
Contacts
Press contact PLAYMOBIL:
PLAYMOBIL Press Office, pr@playmobil.de, Tel. +49 911 9666 1436
Press contact PAPACKS:
PAPACKS Press Office, press@papacks.com, Tel. +49 221 30163006
Images
About PLAYMOBIL
The Horst Brandstätter Group is a global player known for its renowned brands PLAYMOBIL and LECHUZA, delivering quality, innovation, and genuine value to consumers. PLAYMOBIL's imaginative role-playing toy, featuring its 7.5 cm figures, animals, and extensive accessories, has fascinated children for 50 years. With over 3.8 billion figures produced since 1974, PLAYMOBIL’s award-winning play worlds are available in around 100 countries worldwide.
About PAPACKS®
PAPACKS® leads the charge in developing and manufacturing sustainable, plastic-free packaging solutions. Specializing in molded fiber packaging made primarily from tree and hemp fibers, PAPACKS® creates food-safe packaging through advanced technology and environmental commitment. Dedicated to a circular economy, PAPACKS® is reducing plastic pollution and invites businesses worldwide to join the movement toward a sustainable future.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
INTERSPORT Austria acquires INTERSPORT Slovenia Group15.1.2026 15:16:10 CET | Press release
Strategic move strengthens market position in Central Europe, with over 500 locations in 12 countries and more than € 1 billion in sales
VORN Bioenergy announces appointments to leadership team15.1.2026 11:14:45 CET | Press release
Regensburg. VORN Bioenergy today announces the appointment of Jörg Lennertz as Chief Executive Officer and Manuel Fernández Durán as Chief Financial Officer. Jörg and Manuel together with Michael Wallis Olausson form the new management team.
Vyoma’s first Space Domain Awareness satellite has reached orbit13.1.2026 13:42:00 CET | Press release
Munich, 13. January 2026 - Vyoma, a Germany-based company providing Space Domain Awareness (SDA) capabilities, has launched its pioneering surveillance satellite, Flamingo-1, on Sunday, January 11th, 2026 from Vandenberg Space Force Base, California, USA. It was launched aboard the Twilight rideshare mission with SpaceX via Germany-based launch integrator Exolaunch. The satellite was deployed to its operational Sun-synchronous orbit of approximately 500-km in altitude. This marks a significant achievement for the company, which patented the operational concept of an optimized SDA mission. Flamingo-1, equipped with an optical sensor for space-based space surveillance, is a gamechanger for Europe, strengthening SDA efforts directly from orbit. The advanced optical instrument will detect, track and characterize space objects, such as debris and other satellites. Crucially, it will allow Vyoma and its customers to follow up on manoeuvring objects and derive insights into adversary actions
ORTEC expands German healthcare footprint with strategic acquisition of Klages & Partner13.1.2026 09:00:00 CET | Press release
Acquisition adds over 200 healthcare customers and sector-specific workforce management expertise to ORTEC’s portfolio
Acousia Announces Completion of Patient Enrollment in Phase 2 PROHEAR Study Evaluating ACOU085 (INN: Bimokalner) for the Prevention of Cisplatin-Induced Ototoxicity8.1.2026 09:00:00 CET | Press release
Tübingen, Germany, January 8, 2026 Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient enrollment in its Phase 2 PROHEAR clinical study. ACOU085 (INN: Bimokalner) is a proprietary, first-in-class small molecule that has demonstrated robust and reproducible efficacy across multiple preclinical hearing loss models, including drug-induced ototoxicity. The PROHEAR Study is a double-blind, randomized, placebo-controlled, split-body, multicenter Phase 2 trial. It enrolled young male patients with metastatic testicular cancer who are scheduled to receive cisplatin-based chemotherapy. While cisplatin is a highly effective chemotherapeutic agent, cumulative doses of ≥300 mg/m² lead to clinically meaningful, permanent hearing loss in the majority of patients. Fifteen leading university hospitals in Germany are participating in this interdisciplinary study. Patients are randomized
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom